EP2001557A2 - Décoloration réductive - Google Patents

Décoloration réductive

Info

Publication number
EP2001557A2
EP2001557A2 EP07723365A EP07723365A EP2001557A2 EP 2001557 A2 EP2001557 A2 EP 2001557A2 EP 07723365 A EP07723365 A EP 07723365A EP 07723365 A EP07723365 A EP 07723365A EP 2001557 A2 EP2001557 A2 EP 2001557A2
Authority
EP
European Patent Office
Prior art keywords
hydroxy
acid
group
amino
methanesulfinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07723365A
Other languages
German (de)
English (en)
Inventor
Burkhard Müller
Inge Neubueser
Wibke Gross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102006013260A external-priority patent/DE102006013260A1/de
Priority claimed from DE200610022215 external-priority patent/DE102006022215A1/de
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to EP10177131.9A priority Critical patent/EP2283899B1/fr
Publication of EP2001557A2 publication Critical patent/EP2001557A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom

Definitions

  • the invention relates to compositions for reductive color printing, which contains organic sulfinic acid derivatives and has a content of sulfite anions of at most 1, 5 wt .-%.
  • These color proofing agents are suitable for the improved decolorization of colored substrates such as paper, textiles and, in particular, keratin-containing fibers, for example human hair.
  • a process for decolorization of colored substrates, as well as the use of said color proofing agent is the subject of the invention.
  • the dye In dyeing, the dye is transferred to the substrate by adsorption to the surface, by diffusion, by formation on and / or in the substrate, or by chemical bonding.
  • natural dyes such as purple or carmine were used.
  • tailor-made synthetic dyes have become available over the years for each application.
  • Oxidative dyes are formed by oxidative coupling of one or more developer components with each other or with one or more coupler components. Coupler and developer components are also referred to as oxidation dye precursors.
  • the oxidative coupling preferably takes place during the dyeing process so that the dye precursors can diffuse into the substrate and the dye forms in the substrate.
  • the size of the resulting dye molecule makes it difficult to wash out of the substrate.
  • primary aromatic amines having a further free or substituted hydroxy or amino group in the para or ortho position diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazolone derivatives and 2,4,5,6-tetraaminopyrimidine and its derivatives are used as development nuclei pone ⁇ te ⁇ .
  • m-phenylenediamine derivatives naphthols, resorcinol and resorcinol derivatives, pyrazolones, m-aminophenols and substituted pyridine derivatives are generally used.
  • Suitable coupler substances are in particular ⁇ -naphthol, 1, 5, 2,7- and 1, 7-dihydroxynaphthalene, 5-amino-2-methylphenol, m-aminophenol, resorcinol, resorcinol monomethyl ether, m-phenylenediamine, 2,4 -Diaminophenoxyethanol, 2-amino-4- (2-hydroxyethylamino) -anisole (Lehmann's Blue), 1-phenyl-3-methyl-pyrazol-5-one, 2,4-dichloro-3-aminophenol, 1, 3-bis - (2,4-diaminophenoxy) -propane, 2-chlororesorcinol, 4-chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 3-amino-6-methoxy-2-methylamino pyridine and 3,5-diamino-2,6-dimethoxypyridine
  • Direct-acting dyes are generally understood to be dyes which are already preformed before the beginning of dyeing and are applied to the substrate.
  • Important representatives of this class of dyes are, for example, triphenylmethane dyes, azo dyes, anthraquinone dyes or nitrobenzene dyes, which may each carry cationic or anionic groups.
  • Oxidative discoloration usually leads to good results.
  • the structure of the substrate can be chemically altered by the strong oxidizing action of the decolorizing oxidizing agent. This goes with an undesirable physical change of the Substrate accompanied. For example, textiles or hair can become brittle or even break, especially if they are discolored several times. The visual impression, the feel as well as the durability of the substrate are negatively influenced.
  • reductive decolorizing agents scarcely discolour the natural hair color but have a reductive effect only on the dyes applied by dyeing. There is thus hardly any whitening of the hair.
  • the reductive decolorants require an improvement in decolorization performance.
  • reductive sulfur compounds for decolorization.
  • dithionites or derivatives of 1-hydroxymethylsulfinic acid or of 1-aminomethylsulfinic acid are suitable as reducing agents.
  • aminoalkanesulfinates of the formula R 1 3-Z N (CR 2 R 3 -SO 2 -M) Z (R 2 , R 3 hydrogen or (C 1 to C 4 ) Alkyl) for the partial decolorization of dyed or printed with vat dyes or sulfur dyes textiles.
  • 1-hydroxyalkylsulfinic acids or 1-aminoalkylsulfinic acids which carry a carboxy group, a sulfonic acid group, an acyl group, an aminocarbonyl group or an alkoxycarbonyl group are suitable for decolorization of colored substrates.
  • Said derivatives have a comparable or better decolorizing power as the 1-hydroxymethylsulfinic (vide supra).
  • W0-A1 -02 / 30369 describes the discovery that with the sulfinic acid derivatives of WO-A1 -99 / 18067 keratin-containing fibers, such as, for example, hair, can be decolorized.
  • Further sulfinic acid derivatives which are suitable for decolorizing keratin-containing fibers can be found in the publications W0-A1 -03 / 026597 and WO-A1-03 / 41668.
  • the object of the present invention is to provide in the Entfärbeieistung improved reductive Entfärbesch that permanently discolor the substrate without darkening. The substrate structure should be spared. Furthermore, the reducing agents used in the decolorizing agents for a cosmetic use should be physiologically acceptable and toxicologically harmless.
  • the object is achieved by means which comprise at least one of the organic sulfinic acid derivatives according to the invention and does not exceed a maximum content of sulfite anions.
  • the decolorization of colored substrates, such as paper, textiles or keratin fibers, in particular human hair, succeeds better without darkening to a high degree after the decolorization process, as is caused by the use of the sulfinic acid derivatives alone.
  • the compositions according to the invention are particularly suitable for the fiber-sparing decolorization of keratin-containing fibers.
  • keratin fibers are, for example, wool, furs, feathers and especially human hair to understand.
  • a first subject of the invention are therefore agents which comprise in a carrier at least one sulfinic acid derivative of the formula (I),
  • M is a hydrogen atom or one equivalent of a mono- or polyvalent cation
  • R is derived from a peptide or is a radical according to one of the formulas (II) to (VI),
  • mean Y and Y independently of one another represent a hydroxyl group, an -NH 2 group or a group -NR 3 R 4 , where R 3 and R 4 independently of one another represent a (C 1 to C 6 ) -alkyl group, a (C 2 to C 6 ) Alkenyl group, a (C 1 to C 6 ) hydroxyalkyl group, a (C 2 to C 6 ) polyhydroxyalkyl group, an aryl group or an ArVl (C 1 to C 6 ) alkyl group,
  • X is a direct bond or an organic radical with two free ones
  • R 1 and R 14 independently represent a hydrogen atom, a (Ci to C 6 ) - alkyl group or a carboxyalkyl group - (CH 2 ) m -COOM ", in which M” stands for a hydrogen atom or for one equivalent of a mono- or polyvalent cation and m is the number 0, 1 or 2,
  • R 2 is a hydrogen atom, a (Ci to C 6 ) alkyl group, a carboxyalkyl - - (CH 2 ) n -COOM '"with
  • M 1 hydrogen atom or one equivalent of a mono- or polyvalent cation and n is an integer 0, 1, 2, 3, 4, 5 or 6, a (C 1 to C 6 ) -alkyloxycarbonyl radical, a sulfonic acid group, a carbamoyl group, N 1 N-DiI (C 1 to C 6) alkyl] carbamoyl group, N, N, N-tri [(Ci to C6) alkyl] ammonium (Ci to C6) alkyl group, a carboxy- ( C 2 to C 6) alkenyl group, a cyano ⁇ alkyl to C 6) or a (Ci-C 6) alkoxycarbonyl (C 1 to C 6 alkyl group), an aliphatic or aromatic heterocycle which may be substituted , or a radical according to formula (IV) or
  • R 2 forms, together with R 1 and the remainder of the molecule, an aliphatic 5-, 6- or 7-membered ring which contains at least one cationic, quaternized nitrogen atom as heteroatom, the cationic charge optionally being compensated by one equivalent of a mono- or polyvalent anion becomes,
  • R 7 is a carboxy group, a sulfonic acid group, a (C 1 to C 6 ) -
  • R 1 R 11 R 1 " independently represent a (C 1 to C 6 ) alkyl group, a (C 2 to C 6 ) alkenyl group, an Ar ⁇ (C 1 to C 6 ) alkyl group or a (C 1 to C 6 ) hydroxyalkyl group
  • R 8 and R 9 are independently a hydrogen atom, a (C, to C 6) - alkyl group, a (C 2 to C 6) alkenyl group, a (C 1 -C 6) - hydroxyalkyl group, a (C 2 to C 6 ) Polyhydroxyalkyl group, a (C 1 to C 6 )
  • R 10 (! C to C 6) alkyl group, a (C 1 to C 6) alkyl group, an optionally substituted aryl group, an optionally substituted heteroaryl group, a carboxy, carboxy (C 2 -C 6) alkenyl group, a (C 1 to C 6 ) alkoxycarbonyl group or a (C 1 to C 6 -alkoxycarbonyKC ! To C 6 ) -alkyl group,
  • R 11 , R 12 and R 13 are each independently a hydrogen atom, a (C 1 to C 6 ) -
  • Alkyl group a (C 2 to C 6 ) alkenyl group, a Pe ⁇ UOr- (C 1 to C 6 ) alkyl group, a (C 3 to C 6 ) cycloalkyl group, an optionally substituted aryl group, an optionally substituted heteroaryl group, a (C 1 to C 6 ) -hydroxyalkyl group, a (C 2 to C 6 ) -polyhydroxyalkyl group, an Ar 1 - (C 1 to C 6 ) -alkyl group, a C 1 -O xy- (C 1 to C 6 ) -alkyl group, a carboxy (C 2 -C 6) alkenyl group or a (C 1 -C 6) - alkoxycarbonyl (C- ⁇ -C 6) alkyl group, with the proviso that in formula (II) R 1 and R 2 are not simultaneously a hydrogen atom, wherein at most 1, 5 wt .-% of s
  • the compounds of the formula (I) can be present in the form of the free acid or salt thereof as the inner salt, especially if, in addition to the sulfinate group of the formula (I), a cationic substituent (see definition R 2 and R 7 ) is contained in the molecule.
  • the radicals M, M ', M "and / or M 1 " represent a hydrogen atom.
  • the fragments MO of the formula (I), M 1 O- of the formula (III) and M 11 O- or M 111 O- according to R 1 or R 2 from formula (II) in this case form a hydroxy group.
  • the sulfinic acid of the formula (I) is in the form of a salt, at least one of the radicals M, M ', M “or M 1 " is for one equivalent of a mono- or polyvalent cation.
  • the monovalent or polyvalent cation M z + with a charge number z of one or higher is only used for reasons of electroneutrality to compensate for the single negative charge of salt formation
  • OSR present sulfinate fragment of formula (I) or mutatis mutandis from formula (III), or the carboxylate fragments of the radicals of R 1 or R 2 of the formula (II).
  • the equivalent of the corresponding cation to be used is 1 / z.
  • M z + the fragment M'O-
  • all cations which do not undergo a redox reaction with the remaining sulfinate fragment of the formula (I) are suitable as corresponding mono- or polyvalent cations.
  • these are metal cations of the physiologically acceptable metals from groups Ia, Ib, IIa, IIb, IIIb, VIa or VIII of the Periodic Table of the Elements, ammonium ions, as well as cationic organic compounds with quaternized nitrogen atom.
  • the latter are formed for example by protonation of primary, secondary or tertiary organic amines with an acid, such as with compounds of formula (I) in their acidic form, or by permanent quaternization of said organic amines.
  • Examples of these cationic organic ammonium compounds are 2-ammonioethanol and 2-trimethylammonioethanol.
  • M, M ', M 1 ' and M 1 are preferably each independently a hydrogen atom, an ammonium ion, an alkali metal ion, half a equivalent of an alkaline earth metal ion or half an equivalent of a zinc ion, more preferably a hydrogen atom, an ammonium ion Sodium ion, a potassium ion, V2 calcium ion, V. magnesium ion or Vz zinc ion.
  • the equivalent of the optionally present mono- or polyvalent anions according to formula (I) is described analogously to the definition of the cation equivalents to maintain the electroneutrality by formulating a stoichiometric coefficient of less than 1 before the name of the anion.
  • the said anions are described below as being " anionic " and are preferably selected from halide, Vz sulfate, hydrogensulfate, Vz carbonate, hydrogen carbonate, 1/3 phosphate, Vz hydrogen phosphate, dihydrogen phosphate or p-toluenesulfonate , Bromide, p-toluenesulfonate or hydrogen sulfate.
  • those sulfinic acid derivatives according to formula (I) are furthermore preferred in which the radicals Y of the formula (II) or formula (III) and Y 'of the formula (IM) independently of one another represent a hydroxy group or a group -NH 2 .
  • Sulfinic acid derivatives in which R 1 is a hydrogen atom or a methyl group are preferred according to the invention.
  • R is a radical of the above formulas (II) to (VI).
  • radical R of the formula (I) is a radical of the abovementioned formula (II)
  • the preferred sulfinic acid derivative of the formula (Ia) according to the invention results from the formula (I) as the preferred first embodiment
  • the radical R 2 according to formula (II) or formula (Ia) is an aliphatic or aromatic heterocycle, which may be optionally substituted. If the abovementioned selected aliphatic or aromatic heterocycles of this embodiment are substituted, these are preferably with at least one radical of (C 1 to C 6 ) -alkyl, (C 2 to C 6 ) -alkenyl, (C 1 to C 6 ) - Hydroxyalkyl, AlyI- (C 1 to C 6 ) alkyl, hydroxy, (C 1 to C 6 ) alkoxy, amino, di (C 1 to C 6 ) alkylamino, nitro, halogen, carbamoyl, sulfonamido, cyano or carboxamido , substituted.
  • M 1 Y and R 1 have the meanings defined under formula (I),
  • Z 1 represents an oxygen atom, a sulfur atom or a group NR ⁇ v , wherein R ⁇ v is a hydrogen atom, a (C 1 to C 6 ) alkyl group, a (C 2 to C 6 ) alkenyl group, a (C 1 to C 6 ) hydroxyalkyl group or an aryl (C 1 to C 6 ) alkyl group,
  • Z 2 and Z 3 independently of one another represent a CH group or a nitrogen atom
  • R 5 and R 6 independently of one another represent a hydrogen atom, a (C 1 to C 6 ) -alkyl group, a (C 2 to C 6 ) - alkenyl group, a (C 1 to C 6) hydroxyalkyl group, a hydroxy group, a (C 1 to C 6) alkoxy group, an amino group, a di (Ci to C 6) alkylamino group, a nitro group, a halogen atom, a carbamoyl group, an Sulfonamido group, a cyano group or a carboxamido group or together form a Benzanellleiter, which in turn may be substituted.
  • radical Z 1 forms an azandiyl group -NR IV in the ring of the heterocycle.
  • the benzanellation from the radicals R 5 and R 6 of the formula (Ia-1) to (Ia-4), when substituted, is preferably at least one radical of (C 1 to C 6 ) alkyl, (C 2 to C 6 ) alkenyl, (C 1 to C 6 ) -hydroxyalkyl, ArVl- (C 1 to C 6 ) -alkyl, hydroxy, (C 1 to C 6 ) -alkoxy, amino, di (C 1 to C 6 ) alkylamino, nitro, halogen, carbamoyl, sulfonamido, cyano or carboxamido substituted.
  • R 5 and R 6 according to the formulas (la-1) to (la-4) are particularly preferably a hydrogen atom, a hydroxy group, a (Ci to C6) alkyl group, a (C 1 to C 6) alkoxy, (C 1 to C 6 ) - hydroxyalkyl group, halogen atom or nitro group.
  • M means the definitions described under formula (I) or a negative charge
  • Z 8 , Z 9 and Z 10 one of these radicals is an azonium diyl group N + R V R VI with R v and R v ⁇ independently of one another represent a (C 1 to C 6 ) -alkyl group, a (C 2 to C 6 ) Alkenyl group, a (Ci to C 6 ) - hydroxyalkyl group or an ArVl (C 1 to C 6 ) alkyl group, and the remaining of these radicals are a CH 2 group, R 17 and R 18 are independently a hydrogen atom, a (Ci to C 6 ) -alkyl group, a
  • the CH 2 group forms a methanediyl fragment -CH 2 - in the ring of the heterocycle, which of course may also be substituted by one of the radicals R 17 or R 18 .
  • radical R 2 of the formula (II) is a radical of the abovementioned formula (IV), then the formula (I) results in the sulfinic acid derivative of the formula according to the invention
  • R 7 is a carboxy group, a sulfonic acid group or a group -N + R 1 R 11 R 1 ", R 1, R" and R 1 " independently of one another is a (C 1 to C 6 ) -alkyl group, a (C 2 to C 6 ) -alkenyl group, an ArVl (C 1 to C 6 ) -alkyl group or a (C 1 to C 6 ) -hydroxyalkyl group, and Radicals R 8 and R 9 represent a hydrogen atom.
  • n in formula (Ia-8) is a number 0, 1 or 2.
  • radical R of the formula (I) is a radical of the abovementioned formula (III)
  • the sulfinic acid derivative of the formula (Ib) according to the invention results from the formula (I) as preferred second embodiment of the invention
  • the radical X is preferably an organic radical having two free valencies.
  • Suitable radicals according to the invention are in principle all organodiyl radicals, such as, for example, aliphatic or alicyclic, aromatic or heteroaromatic diyl radicals.
  • the said organic radical having two free valencies X according to formula (III) or formula (Ib) is preferably selected from the group consisting of optionally substituted radicals of arendiyl, heteroarendiyl, alkanediyl, alkenediyl, cycloalkanediyl, cycloalkendiyl and DK (C 1 to C 6 ) alkylene) - substituted carbocyclic or heterocyclic groups which are aliphatic or aromatic.
  • radicals of this embodiment are substituted, these are preferably having at least one radical of (C 1 to C 6 ) -alkyl, (C 2 to C 6 ) -alkenyl, (C 1 to C 6 ) -hydroxyalkyl, ArVl (C 1 to C 6 ) alkyl, hydroxy, (C 1 to C 6 ) alkoxy, amino, di (C 1 to C 6 ) alkylamino, nitro, halogen, carbamoyl, sulfonamido, cyano or carboxamido substituted.
  • radical X of the formula (III) or of the formula (Ib) is an organic radical having two free valences selected from a (C 1 to C 6 ) alkanediyl group or from radicals of the formulas ( VII) to (Xl) is selected,
  • R 15 and R 16 independently of one another represent a hydrogen atom, a halogen atom, a (C 1 to C 6 ) -alkyl group or a carboxy group, n is an integer from 0 to 6,
  • Z 4 is a group CH 2 , an oxygen atom, a sulfur atom or a group
  • R' hydrogen atom, a (C 1 to C 6) alkyl group, a (C 1 -C 6) - hydroxyalkyl group or a (C 2 -C 6) polyhydroxyalkyl group,
  • Z 5 , Z 6 and Z 7 are independently a group CH or a nitrogen atom.
  • the organic radical having two free valencies X is selected from the formulas (VII) and (VIII), the radicals are 2-chloro-cyclopentane-1, 3-diyl, 2-bromo-cyclopentane-1,3-diyl, 2 Chloro-cyclohexane-1, 3-diyl and 2-bromo-cyclohexane-1, 3-diyl preferred representatives.
  • radical R of the formula (I) is a radical of the abovementioned formula (IV)
  • the formula (I) results in the sulfinic acid derivative of the third embodiment of the formula (Ic) according to the invention
  • radicals R according to formula (IV) which are selected from 4-cyanophenyl, 4-carboxyphenyl, 4-carboxymethyloxy and 4-trimethylammoniophenyl. If the radical R of the formula (I) is a radical of the abovementioned formula (V), the formula (I) results in the sulfinic acid derivative of the fourth embodiment according to the formula (Id) according to the invention,
  • radical R of the formula (I) is a radical of the abovementioned formula (VI)
  • the formula (I) results in the sulfinic acid derivative of the fifth embodiment of the formula (Ie) according to the invention
  • Examples of (C 1 to C 6) alkyl groups are linear, branched or cyclic (Ci to C6) alkyl groups, wherein lieneare or branched (Ci to C6) alkyl groups are preferred.
  • the groups methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, n-pentyl and n-hexyl are suitable.
  • Examples of correspondingly suitable cyclic alkyl groups are cyclopentyl and cyclohexyl.
  • Examples of preferred (C 2 to C 6 ) alkenyl radicals are vinyl, allyl and butenyl.
  • Preferred (C 1 to C 6 ) -alkoxy radicals according to the invention are, for example, a methoxy or an ethoxy group.
  • the methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, sec-butoxycarbonyl and tert-butoxycarbonyl groups are examples of (C 1 to C 6 ) alkoxycarbonyl groups; the methoxycarbonyl and ethoxycarbonyl groups are particularly preferred.
  • Butoxycarbonylpropyl and 3-tert-butoxycarbonylpropyl groups are examples of (C 1 to C 6 ) -
  • AlkoxycarbonyHCi to C 6 ) alkyl groups AlkoxycarbonyHCi to C 6 alkyl groups.
  • cyano-fCi to C 6 ) -alkyl groups are cyanomethyl, 2-cyanoethyl,
  • 2-hydroxyethyl group is particularly preferred.
  • Examples of a (C 2 to C 6 ) -polyhydroxyalkyl group are the 2,3-dihydroxypropyl group, 3,4-
  • Methoxyhexyl distrin are examples of inventive (C 1 to C 6 ) alkoxy (Ci to C 6 ) - alkyl groups.
  • a preferred hydroxy (C! -C 6) alkoxy group is the 2-hydroxyethoxy group.
  • Aryl groups are phenyl, naphthyl and biphenyl.
  • Preferred heteroaryl groups are thienyl, furyl, pyrrolyl, imidazolyl, thiazolyl, oxazolyl,
  • the trifluoromethyl and the pentafluoroethyl are preferred Pe ⁇ UOr- (C 1 to C 6 ) - alkyl groups.
  • halogen atoms are F, Cl, Br or I atoms, with Cl and Br atoms being very particularly preferred.
  • Preferred ArVl (C 1 to C 6 ) alkyl groups are benzyl and 2-phenylethyl.
  • the trimethylammonium and diethylmethylammonium are examples of a group
  • the 2-trimethylammoniumethyl is an example of an N, N, N-tri [(C 1 to C 6 ) -alkyl] ammonium (C 1 to C 6 ) alkyl group.
  • a preferred (C 1 to C 6 ) carboxyalkyl group is the 3-carboxypropyl group.
  • Very particularly preferred representatives of the sulfinic acid derivatives of the formula (I) are the sulfinic acids according to the list below or salts thereof with one equivalent of at least one mono- or polyvalent cation:
  • the sulfinic acids of the formula (I) used according to the invention are prepared, for example, from the reaction of dithionite with corresponding aldehydes or ketones analogously to the preparation according to WO-A1-99 / 18067.
  • the agent according to the invention contains at least one sulfinic acid derivative of the formula (I) in an amount of 0.01 to 20 wt .-%, particularly preferably from 1 to 20 wt .-%, each based on the weight of the composition.
  • the damage to the substrates is lower than with corresponding sulfinic acid decolorizing agents having a high sulfite content.
  • the amount of Sulfitanion (SO 3 2 ' , molecular weight 80.06 g / mol) is calculated according to the invention as a weight percent of Sulfitanion of the sulfite-containing compounds, that is, counterions and other components of the sulfite-containing compounds are not taken into account in the calculation. It is inventively preferred if the inventive compositions at most 1, 5 wt .-%, more preferably at most 1, 0 wt .-%, most preferably at most 0.5 wt .-%, of sulfite anions, each based on the weight of ready to use agent, included.
  • such agents which contain in a carrier at least one sulfinic acid of the above formula (I), with the proviso that all the raw materials used for the preparation of this agent in their amounts used to provide the agent according to the invention before mixing in Sum of at most 1.5 wt .-%, preferably at most 1, 0 wt .-%, particularly preferably at most 0.5 wt .-% of sulfite anions, each based on the weight of the said raw materials provided, Applicable Mitteis, included.
  • the sulfite anion content is calculated as previously described.
  • the ready-to-use agent can already be offered as a finished application mixture with an acidic pH. However, it may be favorable to produce the ready-to-use agent only immediately before or during application to the substrate. To do this, either
  • the amounts of sulfite anion contained in the composition of the invention need not necessarily be completely dissolved in the carrier. It has been found that also undissolved sulfitanionen lounge compounds adversely affect the parameters of Haars deal and the strength of the brightening, as long as these sulfitanionen restroomn compounds dissolve at least partially.
  • the agents according to the invention additionally comprise at least one compound selected from the aldehydes and / or the ketones.
  • the choice of compounds from the aldehydes or ketones is initially no limit. At least one representative from the group that is formed proves to be particularly suitable:
  • the keto group (s) may be (endocyclically) bonded (and / or) or exocyclically.
  • Oxocarboxylic acids are organic compounds which, in addition to at least one carboxyl group, carry a carbonyl group and are thus aldehyde or ketocarboxylic acids.
  • Preferred oxocarboxylic acids are ⁇ -oxocarboxylic acids, ⁇ -oxocarboxylic acids, ⁇ -oxocarboxylic acids and ⁇ -oxocarboxylic acids of the formula (XII) or salts thereof,
  • R is a hydrogen atom, a (C 1 to C 6 ) alkyl group, a (C 1 to C 6 ) hydroxyalkyl group, an optionally substituted aryl group, an optionally substituted heteroaryl group, a (C 2 to C 6 ) alkenyl group or a carboxy (C 1 to C 6 ) alkyl group, n is a number 0, 1, 2 or 3.
  • the oxocarboxylic acids are particularly preferably selected from at least one member from the group consisting of glyoxylic acid, acetoacetic acid, 3-oxoglutaric acid, 4-oxovaleric acid and pyruvic acid or the salts of the abovementioned acids.
  • the oxocarboxylic acid esters are preferably selected from (C 1 to C 6 ) -alkyl esters of the preferred oxocarboxylic acids according to the invention.
  • cyclic, linear or branched aliphatic aldehydes are aliphatic aldehydes whose formyl group (s) are not in conjugation with an aromatic ⁇ -electron system.
  • the corresponding aldehydes may carry aromatic radicals as long as the ⁇ -electrons of the formyl group (s) can not be delocalized via such an aromatic system.
  • Preferred cyclic, linear or branched aliphatic Aldehydes are saturated or unsaturated and are more preferably selected from at least one of formaldehyde, acetaldehyde, glyoxal, propionaldehyde, butanal, pentanal, isopentanal, hexanal, cyclohexanal, heptanal, octanal, malondialdehyde, glutaraldehyde, 2-methylpentanal, 2-ethylhexanal , 3,5,5-trimethylhexanal, 2-ethylbutyraldehyde, 2-methylbutyraldehyde, isobutyraldehyde, 3-phenylpropanal, 3- (4-methylphenyl) propanal, 3- (4-methoxyphenyl) propanal, 3- (2-methoxyphenyl) propanal, 2-butenal, acrolein, 3-methyl-2-butenal, 3,7
  • cyclic, linear or branched aliphatic ketones mean aliphatic ketones whose keto group (s) are not in conjugation with an aromatic ⁇ -electron system.
  • the corresponding ketones may carry aromatic radicals as long as the ⁇ electrons of the keto group (s) can not be delocalized via such an aromatic system.
  • Preferred cyclic, linear or branched aliphatic ketones are saturated or unsaturated and selected from at least one member selected from the group acetone, 2-butanone, 2-pentanone, 3-pentanone, 2-hexanone, 3-hexanone, butane-2,4-dione , Pentane-2,4-dione, hexane-2,5-dione, cyclohexanone, cyclopentanone, 4-methylpentan-2-one, 5-methyl-3-hexen-2-one, 2- (3-oxopropyl) benzoic acid methyl ester and 4- (3-oxopropyl) benzoic acid methyl ester.
  • Preferred monohydroxy-functionalized aldehydes are selected from at least one member selected from the group consisting of 1-hydroxypropanal, 5-hydroxypentanal, 3,7-dimethyl-7-hydroxyoctanal, hydroxyisohexyl-S-cyclohexene-i-carboxaldehyde and 2,6,6-trimethyl-1 , 3-cyclohexadiene-1-carboxaldehyde.
  • Polyhydroxy-functionalized aldehydes are according to the invention preferably the so-called aldoses and are particularly preferably selected from at least one member selected from the group consisting of 2,3-dihydroxypropionaldehyde, D-erythrose, D-threose, D-ribose, D-arabinose, D-lyxose, D-xylose, D-allose, D-altrose, D-galactose, D-glucose, D-idose, D-mannose, D-rhamnose and D-talose, as well as the L-configurations L-erythrose, L-threose, L-ribose, L Arabinose, L-lyxose, L-xylose, L-allose, L-altrose, L-galactose, L-glucose, L-idose, L-mannose, L-rhamnose and L-talose.
  • Monohydroxy-functionalized ketones which are particularly suitable according to the invention are preferably selected from at least one member selected from the group consisting of 1-hydroxy-2-propanone, 1-hydroxy-2-butanone, 3-hydroxy-2-butanone and benzoin.
  • Polyhydric-functionalized ketones are preferably the so-called ketoses according to the invention and are more preferably selected from at least one member of group 1, 3-dihydroxyacetone, D-psicose, D-fructose, D-sorbose, D-tagatose, D-ribulose, D-xylulose, D-erythrulose and the L-configurations L-psicose, L-fructose, L-sorbose, L-tagatose, L-ribulose, L-xylulose, L-erythrulose.
  • Preferred alicyclic, aromatic or heterocyclic ketones are preferably selected from at least one member of the group
  • Preferred alicyclic, aromatic or heterocyclic aldehydes are preferably selected from at least one member of the group
  • the derivatives of benzaldehydes, naphthaldehydes or cinnamaldehydes are preferably selected from at least one member from the group of benzaldehyde, naphthaldehyde, 2-methylbenzaldehyde, 3-methylbenzaldehyde, 4-methylbenzaldehyde, 4-hydroxy-3-methoxybenzaldehyde, 3,5-dimethoxy-4 -hydroxybenzaldehyde, 4-hydroxy-1-naphthaldehyde, 4-hydroxy-2-methoxybenzaldehyde, 3,4-dihydroxy-5-methoxybenzaldehyde, 3,4,5-
  • All aldehyde or keto compounds should be selected from physiologically acceptable or non-toxic compounds if the agent according to the invention is to be used as a cosmetic agent.
  • the compounds selected from aldehydes or ketones are according to the invention preferably in an amount of 0.1 wt .-% to 20 wt .-%, in particular from 0.5 wt .-% to 10 wt .-%, each based on the Weight of the ready-to-use agent contained in the composition according to the invention.
  • the compositions according to the invention are generally prepared in such a way that at least one sulfinic acid derivative of the formula (I) and at least one compound selected from the aldehydes and / or the ketones are mixed with the carrier with stirring. It is immaterial in which order the two components are added to the presented carrier.
  • At least one sulfinic acid derivative of the formula (I) and at least one compound selected from the aldehydes and / or the ketones can be initially introduced into a mixing vessel and the carrier added with stirring. It may be preferred according to the invention to provide the agent according to the invention with the proviso that the compounds used in the agent according to the invention, selected from the aldehydes and / or the ketones, must be different from those aldehydes or ketones, from which those sulfinic acids are derived, which are actually contained in the agent according to the invention.
  • the agent according to the invention additionally contains at least one reductone.
  • a reductone is understood by those skilled in the art to be reductive endiol compounds which are stabilized by substitution in the ⁇ position and undergo tautomerism.
  • the most important reductones which can be used according to the invention are ascorbic acid, isoascorbic acid, 2,3-dihydroxy-2-propen-dial and 2,3-dihydroxy-2-cyclopentenone.
  • the reductones are inventively preferably in an amount of 0.1 wt .-% to 20 wt .-%, in particular from 0.5 wt .-% to 10 wt .-%, each based on the weight of the ready-to-use agent, in the contain agents according to the invention.
  • Suitable carriers for the agent according to the invention are preferably liquid media in which the sulfinic acid derivative according to the invention is preferably soluble, for example water or organic solvents. It is preferred according to the invention if the carrier is a cosmetic carrier.
  • cosmetic carriers are particularly suitable creams, emulsions, gels or surfactant-containing foaming solutions, such as shampoos, foam aerosols or other preparations which are particularly suitable for use on the hair. But it is also conceivable to integrate the ingredients in a powdered or tablet-like formulation, which is dissolved in water before use.
  • the cosmetic carriers may in particular be aqueous or aqueous-alcoholic.
  • aqueous cosmetic carrier contains at least 50% by weight of water.
  • aqueous-alcoholic cosmetic carriers are to be understood as meaning aqueous solutions containing from 3 to 70% by weight of a C 1 -C 4 -alkyl alcohol, in particular ethanol or isopropanol.
  • Further alcoholic solvents are, for example, methoxybutanol, benzyl alcohol, 2-phenoxyethanol, ethyldiglycol or 1,2-propylene glycol.
  • the inventive composition additionally contains, as solvent, at least one (C 2 to C 6 ) -alkyl monoalcohol and / or a (C 2 to C 6 ) -alkanediol, in particular ethanol, isopropanol and / or 1,2-propylene glycol.
  • the agent according to the invention preferably has a pH of from pH 1 to pH 9, in particular from pH 1.5 to pH 6.
  • Suitable pH-adjusting agents are, for example, edible acids, such as citric acid, tartaric acid, lactic acid or malic acid, or phosphoric acid, and also ammonia, Alkalimetasilicates, alkali metal hydroxides or alkanolamines, such as 2-aminoethanol or 2-amino-2-methylpropanol.
  • the agents contain at least one surfactant, wherein in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants are suitable. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
  • Suitable anionic surfactants in preparations according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. Example, a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 10 to 22 C-men men. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule. Examples of suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanol ammonium salts with 2 or 3 C atoms in the alkanol group,
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2 to 15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 carbon atoms.
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule and in particular salts of saturated and in particular unsaturated C 8 -C 22 carboxylic acids, such as oleic acid, stearic acid, isostearic acid and palmitic acid.
  • Zwitterionic surfactants are surface-active compounds which have in the molecule at least one quaternary ammonium group and at least one -COO * '' - or -SO 3 Wear () group.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyl-dimethylammonium glycinate, and 2-alkyl 3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by
  • Ampholytic surfactants are surface-active compounds which, in the 3 H-group in addition to a C 8- i 8 alkyl or acyl group in the molecule at least one free amino group and at least one -COOH or -SO and which are capable of forming inner salts
  • suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 18 C Atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are the N-cocoalkylaminopropionate, the cocoacylaminoethylaminopropionate and the C 12 -i8
  • Nonionic surfactants contain as hydrophilic group z.
  • Such compounds are, for example
  • Alkylphenols having 8 to 15 C atoms in the alkyl group having 8 to 15 C atoms in the alkyl group
  • Further cationic surfactants which can be used according to the invention are the quaternized protein hydrolysates.
  • cationic silicone oils such as, for example, the commercially available products Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone), Dow Corning 929 emulsion (containing a hydroxylamino-modified silicone, which is also referred to as amodimethicone) , SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® quat 3270 and 3272 (manufacturer: Th. Goldschmidt; di- quaternary polydimethylsiloxanes, quaternium-80).
  • Alkylamidoamines in particular fatty acid amidoamines, such as the stearylamidopropyldimethylamine obtainable under the name Tego Amid® S 18, are distinguished, in addition to a good conditioning effect, especially by their good biodegradability. Also very good biodegradability are quaternary Ester für styrene, so-called “esterquats”, dialkoyloxyalkylammoniummethosulfate such as those sold under the trademark Stepantex ® methyl hydroxyalkyl.
  • a suitable cationic surfactant quaternary sugar derivative is the commercial product Glucquat 100 ®, according to CTFA nomenclature a "lauryl methyl Gluceth-10 Hydroxypropyl Dimonium Chloride”.
  • the compounds containing alkyl groups used as surfactants may each be uniform substances. However, it is usually preferred to start from the production of these substances from native plant or animal raw materials, so as to obtain substance mixtures with different, depending on the particular raw material alkyl chain lengths.
  • both products with a "normal” homolog distribution and those with a narrow homolog distribution can be used.
  • "normal” homolog distribution are meant mixtures of homologs obtained in the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates as catalysts. Narrowed homolog distributions are obtained when, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alkoxides are used as catalysts. The use of products with narrow homolog distribution may be preferred.
  • auxiliaries and additives are, for example, nonionic polymers such as vinylpyrrolidone / vinyl acrylate copolymers, polyvinylpyrrolidone and vinylpyrrolidone / vinyl acetate copolymers and polysiloxanes, cationic polymers such as quaternized cellulose ethers, polysiloxanes with quaternaries
  • dimethyldiallylammonium chloride polymers acrylamide-dimethyldiallylammonium chloride copolymers, diethyl sulfate quaternized dimethylaminoethylmethacrylate-vinylpyrrolidone copolymers, vinylpyrrolidone-imidazoliniummethochloride copolymers and quaternized polyvinylalcohol, zwitterionic and amphoteric polymers such as acrylamidopropyltrimethylammonium chloride / acrylate copolymers and Octylacrylamide / methyl methacrylate / tert-butylaminoethyl methacrylate / Z-hydroxypropyl methacrylate copolymers, anionic polymers such as, for example, polyacrylic acids, crosslinked polyacrylic acids, vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / inyl acrylate copolymers, vinyl
  • methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such.
  • bentonite or fully synthetic hydrocolloids such.
  • polyvinyl alcohol structurants such as glucose and maleic acid, hair conditioning compounds such as phospholipids, such as soybean lecithin, egg lecithin and cephalins, and silicone oils,
  • Protein hydrolysates in particular elastin, collagen, keratin, milk protein, soy protein and wheat protein hydrolysates, their condensation products with fatty acids and quaternized protein hydrolysates, perfume oils, dimethyl isosorbide and cyclodextrins,
  • Solubilizers such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol,
  • Anti-dandruff agents such as Piroctone Olamine and Zinc Omadine, other pH adjusters such as ammonia, monoethanolamine, basic amino acids and citric acid
  • Active substances such as panthenol, pantothenic acid, allantoin, pyrrolidonecarboxylic acids and their salts, plant extracts and vitamins, cholesterol, light stabilizers,
  • Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers,
  • Fats and waxes such as spermaceti, beeswax, montan wax, paraffins, fatty alcohols and fatty acid esters, fatty acid alkanolamides,
  • Swelling and penetration substances such as glycerol, propylene glycol monoethyl ether, carbonates, bicarbonates, guanidines, ureas and primary, secondary and tertiary phosphates, imidazoles, tannins, pyrrole, opacifiers such as latex,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air and antioxidants.
  • the constituents of the water-containing carrier are used to prepare the agents according to the invention in amounts customary for this purpose; z. B. emulsifiers in concentrations of 0.5 to 30 wt .-% and thickening agents in concentrations of 0.1 to 25 wt .-% of the total agent used.
  • a second object of the invention is the use of the composition according to the first subject of the invention for the decolorization of substrates which are colored with natural and / or synthetic dyes.
  • the substrate preferably contains synthetic fibers and / or natural fibers.
  • the natural fibers are preferably selected from cellulose-containing fibers, in particular cotton, and keratin-containing fibers, in particular wool or animal or human hair, very particularly preferably from human hair.
  • the synthetic fibers will preferably be selected from polyester, polyamide (such as nylon), elastane, viscose or polyacrylic.
  • the substrates to be decolorized are preferably dyed with oxidation dyes and / or substantive dyes as representatives of the synthetic dyes.
  • developer components used to color the substrate can serve as downstream developer components.
  • G 1 represents a hydrogen atom, a C 1 - to C 4 alkyl radical, a Ci to C 4 - monohydroxyalkyl radical, a C 2 - to C 4 polyhydroxyalkyl radical, a (C 1 - to C 4 J-AIkOXy- ( C 1 - to C 4 ) -alkyl radical, a 4'-aminophenyl radical or a C 1 - to C 4 -alkyl radical which is substituted by a nitrogen-containing group, a phenyl or a 4'-aminophenyl radical;
  • G 2 represents a hydrogen atom, a C 1 - to C 4 -alkyl radical, a d- to C 4 - Monohydroxyalkytrest, a C 2 - to C 4 polyhydroxyalkyl radical, a (C 1 - to C 4 J-AIkOXy- (C 1 - to C 4 ) -alkyl radical or a C 1 - to C 4
  • G 3 represents a hydrogen atom, a halogen atom such as a chlorine, bromine, iodine or fluorine atom, a C 1 - to C 4 -alkyl radical, a C 1 - to C 4 -monohydroxyalkyl radical, a C 2 - to C 4 - Polyhydroxyalkylrest, a C 1 - to C 4 -hydroxyalkoxy, a C 1 - to C 4 -Acetylaminoalkoxyrest, a C 1 - to C 4 - Mesylaminoalkoxyrest or a C 1 - to C 4 -Carbamoylaminoalkoxyrest;
  • a halogen atom such as a chlorine, bromine, iodine or fluorine atom
  • a C 1 - to C 4 -alkyl radical such as a chlorine, bromine, iodine or fluorine atom
  • G 4 represents a hydrogen atom, a halogen atom or a C 1 - to C 4 -alkyl radical or, when G 3 and G 4 are ortho to each other, they may together form a bridging ⁇ , ⁇ -alkylenedioxy group, such as, for example, an ethylenedioxy group ,
  • Particularly preferred p-phenylenediamines of the formula (E1) are selected from p-phenylenediamine, p-toluenediamine, 2-chloro-p-phenylenediamine, 2,3-dimethyl-p-phenylenediamine, 2,6-dimethyl-p-phenylenediamine, 2 , 6-diethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, N, N-dimethyl-p-phenylenediamine, N, N-diethyl-p-phenylenediamine, N, N-dipropyl-p-phenylenediamine, 4 -Amino-3-methyl- (N, N-diethyl) -aniline, N, N-bis- ( ⁇ -hydroxyethyl) -p-phenylenediamine, 4-N, N-bis- ( ⁇ -hydroxyethyl) -amino-2 -methylaniline
  • Very particular preferred p-phenylenediamine derivatives of the formula (E1) according to the invention are p-phenylenediamine, p-toluenediamine, 2- ( ⁇ -hydroxyethyl) -p-phenylenediamine, 2- ( ⁇ , ⁇ -dihydroxyethyl) -p-phenylenediamine and N, N bis (.beta.-hydroxyethyl) -p-phenylenediamine.
  • the dyeing of the substrate may further be preferred for the dyeing of the substrate to use as developer component compounds which contain at least two aromatic nuclei which are substituted by amino and / or hydroxyl groups.
  • binuclear developer components which can be used in the dyeing compositions according to the invention, mention may be made in particular of the compounds corresponding to the following formula (E2) and their physiologically tolerated salts: in which:
  • Z 1 and Z 2 independently of one another represent a hydroxyl or NH 2 radical, which is optionally substituted by a C 1 - to C 4 -alkyl radical, by a C 1 - to C 4 -hydroxyalkyl radical and / or by a bridge Y.
  • the bridging Y is an alkylene group having 1 to 14 carbon atoms, such as a linear or branched alkylene chain or an alkylene ring, which is one or more nitrogen-containing groups and / or one or more heteroatoms such as oxygen or is optionally part of a bridging ring system -, sulfur or nitrogen atoms may be interrupted or terminated and may be substituted by one or more hydroxyl or C 1 - to C 8 -Al koxyreste, or a direct bond,
  • G 5 and G 6 are each independently a hydrogen or halogen atom, a C 1 - to C 4 alkyl radical, a Ci to C 4 monohydroxyalkyl radical, a C 2 - to C 4 - polyhydroxyalkyl radical, a C 1 - to C 4 -aminoalkyl radical or a direct compound for bridging Y,
  • G 7 , G 8 , G 9 , G 10 , G 11 and G 12 independently represent a hydrogen atom, a direct bond to the bridge Y or a C r to C 4 alkyl radical, with the proviso that the compounds of the formula (E2) contain only one bridging Y per molecule.
  • Preferred binuclear developer components of the formula (E2) are in particular: N, N'-bis ( ⁇ -hydroxyethyl) -N, N'-bis (4'-aminophenyl) -1,3-diaminopropan-2-ol, N, N'-bis ( ⁇ -hydroxyethyl) -N, N'-bis (4'-aminophenyl) ethylenediamine, N, N'-bis (4-aminophenyl) tetramethylenediamine, N, N'-bis N, N'-bis (4-aminophenyl) tetramethylenediamine, N, N'-bis (4-methylaminophenyl) tetramethylenediamine, N, N'-diethyl-N, N ' bis (4'-amino-3'-methylphenyl) ethylenediamine, bis (2-hydroxy-5-aminophenyl) methane, N, N'-bis (4'-aminophenyl
  • Very particularly preferred binuclear developer components of the formula (E2) are N, N'-bis ( ⁇ -hydroxyethyl) -N, N'-bis (4-aminophenyl) -1,3-diamino-propan-2-ol, bis - (2-hydroxy-5-aminophenyl) -methane, 1, 3-bis (2,5-diaminophenoxy) -propan-2-ol, N, N'-bis (4-aminophenyl) -1, 4- diazacycloheptane and 1, 10-bis (2,5-diaminophenyl) -1, 4,7,10-tetraoxadecane or one of its physiologically acceptable salts.
  • p-aminophenol derivatives of the formula (E3) it may be preferred according to the invention to use as the developer component a p-aminophenol derivative or one of its physiologically tolerable salts for coloring the substrate to be decolored. Particular preference is given to p-aminophenol derivatives of the formula (E3)
  • G 13 represents a hydrogen atom, a halogen atom, a C 1 to C 4 alkyl radical, a C 1 to C 4 monohydroxyalkyl radical, a C 2 to C 4 polyhydroxyalkyl radical, a (C 1 to C 4 J , alkyl group - (C 4 to C 1) a C 1 - C 4 aminoalkyl -AIkOXy- to, hydroxy (C r to C 4) alkylamino group, a C 1 - to C 4 -Hydroxyalkoxyrest, C 1 - to C 4 -hydroxyalkyl- (C ! -C 4 ) -aminoalkyl or a (di- C 1 - to C 4 -alkylamino) - (C 1 - to C 4 ) -alkyl, and
  • G 14 represents a hydrogen or halogen atom, a C 1 - to C 4 alkyl radical, a Ci to C 4 - monohydroxyalkyl radical, a C 2 - to C 4 polyhydroxyalkyl radical, a (C 1 - to C 4) alkoxy (C 1 to C 4 ) -alkyl radical, a C 1 to C 4 -aminoalkyl radical or a C 1 to C 4 -cyanoalkyl radical,
  • G 15 is hydrogen, C 1 - to C 4 -alkyl, C 1 - to C 4 -monohydroxyalkyl, C 2 - to C 4 -polyhydroxyalkyl, phenyl or benzyl, and
  • G 16 is hydrogen or a halogen atom.
  • Preferred p-aminophenols of the formula (E3) are in particular p-aminophenol, N-methyl-p- aminophenol, 4-amino-3-methyl-phenol, 4-amino-3-fluorophenol, 2-hydroxymethylamino-4-aminophenol, 4-amino-3-hydroxymethylphenol, 4-amino-2- ( ⁇ -hydroxyethoxy) -phenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethyl-phenol, 4-amino-2-aminomethylphenol, 4-amino-2- ( ⁇ -hydroxyethyl-aminomethyl) -phenol, 4-amino-2- ( ⁇ , ⁇ -dihydroxyethyl) phenol, 4-amino-2-fluorophenol, 4-amino-2-chlorophenol, 4-amino-2,6-dichlorophenol, 4-amino-2- (diethyl -aminomethyl) -phenol and their physiologically acceptable salts.
  • Very particularly preferred compounds of the formula (E3) are p-aminophenol, 4-amino-3-methylphenol, 4-amino-2-aminomethylphenol, 4-amino-2- ( ⁇ , ⁇ -dihydroxyethyl) -phenol and 4-amino 2- (diethylaminomethyl) -phenol.
  • the developer component may be selected from o-aminophenol and its derivatives such as 2-amino-4-methylphenol, 2-amino-5-methylphenol or 2-amino-4-chlorophenol.
  • the developer component may be selected from heterocyclic developer components such as the pyridine, pyrimidine, pyrazole, pyrazole pyrimidine derivatives and their physiologically acceptable salts.
  • Preferred pyridine derivatives are, in particular, the compounds described in the patents GB 1 026 978 and GB 1 153 196, such as 2,5-diamino-pyridine, 2- (4-methoxyphenyl) -amino-3-amino-pyridine, 2,3-diamino-6-methoxy-pyridine, 2- ( ⁇ -methoxyethyl) -amino-3-amino-6-methoxy-pyridine and 3,4-diamino-pyridine.
  • Preferred pyrimidine derivatives are, in particular, the compounds described in German Patent DE 2 359 399, Japanese Laid-Open Patent Publication JP 02019576 A2 or in the published patent application WO 96/15765, such as 2,4,5,6-tetraaminopyrimidine, 4-hydroxy- 2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2-dimethylamino-4,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine and 2,5,6- triaminopyrimidine.
  • Preferred pyrazole derivatives are, in particular, the compounds described in patents DE 3 843 892, DE 4 133 957 and patent applications WO 94/08969, WO 94/08970, EP-740 931 and DE 195 43 988, such as 4,5 Diamino-i-methylpyrazole, 4,5-diamino-1- ( ⁇ -hydroxyethyl) pyrazole, 3,4-diaminopyrazole, 4,5-diamino-1- (4'-chlorobenzyl) -pyrazole, 4,5- Diamino-1, 3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3-phenylpyrazole, 4-amino-1,3-dimethyl-5-hydrazinopyrazole, 1-benzyl-4,5-diamino-3-methylpyrazole, 4,5-diamino-3-tert-buty
  • Triaminopyrazole 1-methyl-3,4,5-triaminopyrazole, 3,5-diamino-1-methyl-4-methylaminopyrazole and 3,5-diamino-4- ( ⁇ -hydroxyethyl) amino-1-methylpyrazole.
  • Preferred pyrazolopyrimidine derivatives are, in particular, the derivatives of the pyrazolo [1,5-ajpyrimidine of the following formula (E4) and their tautomeric forms, provided that a tautomeric equilibrium exists:
  • the pyrazolo1, 5-a] pyrimidines of the above formula (E4) can be prepared as described in the literature by cyclization from an aminopyrazole or from hydrazine.
  • the substrates to be decolored were dyed with an oxidative dye which additionally contains at least one coupler component in addition to at least one developer component.
  • coupler components m-phenylenediamine derivatives, naphthols, resorcinol and resorcinol derivatives, pyrazolones and m-aminophenol derivatives are generally used.
  • Suitable coupler substances are in particular 1-naphthol, 1,5-, 2,7- and 1, 7-dihydroxynaphthalene, 5-amino-2-methylphenol, m-aminophenol, resorcinol, resorcinol monomethyl ether, m-phenylenediamine, 1-phenyl-nyl 3-methyl-pyrazolone-5, 2,4-dichloro-3-aminophenol, 1, 3-bis (2 ', 4'-diaminophenoxy) -propane, 2-chloro-resorcinol, 4-chloro-resorcinol, 2 Chloro-6-methyl-3-aminophenol, 2-amino-3-hydroxypyridine, 2-methylresorcinol, 5-methylresorcino
  • Coupler components preferred according to the invention are m-aminophenol and its derivatives, such as, for example, 5-amino-2-methylphenol, N-
  • Resorcinol monomethyl ether 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol, 2- Chlororesorcinol, 4-chlororesorcinol, pyrogallol and 1,2,4-trihydroxybenzene
  • pyridine derivatives such as 2,6-dihydroxypyridine, 2-amino-3-hydroxypyridine, 2-amino-5-chloro-3-hydroxypyridine, 3-amino-2 -methylamino-6-methoxypyridine, 2,6-dihydroxy-3,4-dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6-diaminopyridine, 2,3-diamino-6-methoxypyridine and 3,5-diamino -2,6-dimethoxy,
  • Naphthalene derivatives such as 1-naphthol, 2-methyl-1-naphthol, 2-hydroxymethyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1, 5-dihydroxynaphthalene, 1, 6-dihydroxynaphthalene, 1, 7-dihydroxynaphthalene, 1 , 8-dihydroxynaphthalene, 2,7-dihydroxynaphthalene and 2,3-dihydroxynaphthalene,
  • Morpholine derivatives such as 6-hydroxybenzomorpholine and 6-aminobenzomorpholine,
  • Quinoxaline derivatives such as 6-methyl-1,2,3,4-tetrahydroquinoxaline, pyrazole derivatives such as 1-phenyl-3-methylpyrazol-5-one, indole derivatives such as 4-hydroxyindole, 6-hydroxyindole and 7-hydroxyindole, pyrimidine derivatives such as For example, 4,6-diaminopyrimidine, 4-amino-2,6-dihydroxypyrimidine, 2 > 4-diamino-6-hydroxypyrimidine, 2,4,6-trihydroxypyrimidine, 2-amino-4-methylpyrimidine, 2-amino-4-hydroxy 6-methylpyrimidine and 4,6-dihydroxy-2-methylpyrimidine, or methylenedioxybenzene derivatives such as 1-hydroxy-3,4-methylenedioxybenzene, 1-amino-3,4-methylenedioxybenzene and 1 - (2'-1-hydroxyethyl) - amino-3,4-methylenedioxybenzene and their physiologically acceptable salt
  • coupler components according to the invention are 1-naphthol, 1, 5, 2,7- and 1, 7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4-chlororesorcinol , 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine.
  • the substrates to be decolorized with precursors of naturally-analogous dyes may preferably be dyed with the aid of such indoles and indolines, which preferably have at least two hydroxyl or amino groups, preferably as a substituent on the six-membered ring. These groups may carry further substituents, e.g. Example in the form of etherification or esterification of the hydroxy group or alkylation of the amino group.
  • Particularly suitable precursors of naturally-analogous hair dyes are derivatives of the 5,6-dihydroxyindoline of the formula XIIIa, (XIIIa)
  • G 21 is hydrogen, a C 1 -C 4 -alkyl group or a C 1 -C 4 -hydroxy-alkyl group,
  • G 22 is hydrogen or a -COOH group, where the -COOH group may also be present as salt with a physiologically compatible cation,
  • G, 23 is hydrogen or a C 1 -C 4 -alkyl group
  • - G is hydrogen, a C r C 4 alkyl group or a group -CO-G ⁇ 26 in which G is a C 1 -C 4 alkyl group, and
  • G 25 represents one of the groups mentioned under G 24 , as well as physiologically acceptable salts of these compounds with an organic or inorganic acid.
  • indoline Particularly preferred derivatives of indoline are 5,6-dihydroxyindoline, N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline,
  • N-methyl-5,6-dihydroxyindoline N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline and especially 5, 6-Dihydroxyindolin.
  • G 27 is hydrogen, a C 1 -C 4 -alkyl group or a C 1 -C 4 -hydroxyalkyl group,
  • G 28 is hydrogen or a -COOH group, wherein the -COOH group also as
  • G 29 is hydrogen or a C 1 -C 4 -alkyl group
  • G 30 is hydrogen, a Ci-d-alkyl group or a group -CO-G 32 , in which G 32 is a dC 4 alkyl group, and
  • G 31 stands for one of the groups mentioned under G 30 , as well as physiologically acceptable salts of these compounds with an organic or inorganic acid.
  • Particularly preferred derivatives of indole are 5,6-dihydroxyindole, N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6- dihydroxyindole, 5,6-dihydroxyindole-2-carboxylic acid, 6-hydroxyindole, 6-aminoindole and 4-aminoindole.
  • N-methyl-5,6-dihydroxyindole N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole, and especially the 5,6 -Dihydroxyindol.
  • the substrate to be decolorized may also have been dyed with substantive dyes.
  • Suitable direct dyes include, in particular, nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols.
  • Preferred substantive dyes are those having the international designations or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, Acid Yellow 1, Acid Yellow 10, Acid Yellow 23, Acid Yellow 36, HC Orange Disperse Orange 3, Acid Orange 7, HC Red 1, HC Red 3, HC Red 10, HC Red 11, HC Red 13, Acid Red 33, Acid Red 52, HC Red BN, Pigment Red 57: 1, HC Blue 2, HC Blue 12, Disperse Blue 3, Acid Blue 7, Acid Green 50, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse Black 9, Acid Black 1, and Acid Black 52 known compounds as well as 1 , 4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis ( ⁇ -hydroxyethyl) amino-2-nitrobenzene, 3-nitro-4- ( ⁇ -hydroxyethyl) -aminophenol, 2 - (2'-hydroxyethyl) amino-4,6-dinitrophenol, 1- (2'-hydroxyethyl) amino
  • the substrates to be decolored preferably with a cationic substantive Dyed dye. Particularly preferred are
  • aromatic systems substituted with a quaternary nitrogen group such as Basic Yellow 57, Basic Red 76, Basic Blue 99, Basic Brown 16 and Basic Brown 17, as well as
  • Preferred cationic substantive dyes of group (c) are in particular the following compounds:
  • the compounds of the formulas (DZ1), (DZ3) and (DZ5) are very particularly preferred cationic substantive dyes of group (c).
  • the cationic direct dyes, which are sold under the trademark Arianor ® are, according to the invention particularly preferred substantive dyes.
  • the substrates to be decolorized with naturally occurring, natural dyes such as henna red, henna neutral, henna black, chamomile flower, sandalwood, black tea, buckthorn bark, sage, bluewood, madder root, Catechu, Sedre and alkano root are, be colored.
  • a third object of the invention is a process for the reductive decolorization of substrates dyed with natural and / or synthetic dyes, in which an agent of the first subject of the invention is applied to the dyed substrate and rinsed off again after a contact time.
  • the reaction time is preferably 1 to 60 minutes, preferably 5 to 30 minutes.
  • the action of the drug according to the invention can not only at room temperature but preferably in a temperature range of 15 to 60 ° C, in particular from 25 to 60 0 C take place.
  • the hair is rinsed out, wherein preferably a surfactant-containing agent, such as a cleaning agent or a shampoo, applies.
  • a surfactant-containing agent such as a cleaning agent or a shampoo
  • the substrate can be rinsed out several times, or treated with the surfactant-containing agent.
  • Hydrogen peroxide is preferably used as the oxidizing agent, preferably in concentrations of from 0.5 to 6% by weight.
  • the exposure time is preferred 1 to 30 minutes, more preferably 1 to 10 minutes. After expiry of the contact time, the oxidant-containing composition is rinsed out.
  • Preferred colored substrates are those defined in the second subject of the invention.
  • those dyes were preferably used, as we defined them in the second subject of the invention.
  • a strand of hair (natural hair, Fa. Kerling) was with a commercial oxidative hair color (Igora ® Royal (Schwarzkopf), coloring cream natural clay in a weight ratio of 1 to 1 with the developer Oxigenta ® (6 wt .-% hydrogen peroxide, Schwarzkopf) over a contact time
  • a commercial oxidative hair color Igora ® Royal (Schwarzkopf)
  • Oxigenta ® (6 wt .-% hydrogen peroxide, Schwarzkopf)
  • the tress was dipped in 30 ml of a decolorizer of Table 1 over a residence time of 30 minutes at room temperature, then rinsed with plenty of water and air dried.
  • the stains decolorized with the decolorizing agent E1 according to the invention show less hair damage than the stains decolored with the comparative decolorizing agent V1.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne des agents qui contiennent dans un excipient une combinaison de dérivés spéciaux d'acide sulfinique de formule (I), dans laquelle M représente un atome d'hydrogène ou un équivalent d'un cation monovalent ou multivalent et R est dérivé d'un peptide ou représente un radical selon une des formules (II) à (VI) (Pour la signification des constituants restants, voir la revendication 1), et d'ions sulfite dans une quantité maximale de 1,5 % en poids. Ces agents permettent une décoloration améliorée de substrats teints, sans que lesdits substrats décolorés foncent ultérieurement. Pendant le processus de décoloration, la structure du substrat est épargnée.
EP07723365A 2006-03-21 2007-03-19 Décoloration réductive Withdrawn EP2001557A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10177131.9A EP2283899B1 (fr) 2006-03-21 2007-03-19 Décoloration réductive

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006013260A DE102006013260A1 (de) 2006-03-21 2006-03-21 Organische Sulfinsäurederivate
DE200610022215 DE102006022215A1 (de) 2006-05-11 2006-05-11 Reduktiver Farbabzug
PCT/EP2007/002397 WO2007107309A2 (fr) 2006-03-21 2007-03-19 Décoloration réductive

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP10177131.9A Division EP2283899B1 (fr) 2006-03-21 2007-03-19 Décoloration réductive

Publications (1)

Publication Number Publication Date
EP2001557A2 true EP2001557A2 (fr) 2008-12-17

Family

ID=38522782

Family Applications (2)

Application Number Title Priority Date Filing Date
EP10177131.9A Not-in-force EP2283899B1 (fr) 2006-03-21 2007-03-19 Décoloration réductive
EP07723365A Withdrawn EP2001557A2 (fr) 2006-03-21 2007-03-19 Décoloration réductive

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP10177131.9A Not-in-force EP2283899B1 (fr) 2006-03-21 2007-03-19 Décoloration réductive

Country Status (2)

Country Link
EP (2) EP2283899B1 (fr)
WO (1) WO2007107309A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2967903B1 (fr) * 2010-11-25 2013-04-12 Oreal Composition comprenant un derive de l'acide sulfinique et un epaississant polymerique anionique ou non ionique
DE102019218227A1 (de) * 2019-11-26 2021-05-27 Henkel Ag & Co. Kgaa Verfahren zur Entfärbung von keratinischem Material, das durch Anwendung eines Pigments gefärbt wurde
DE102019218230A1 (de) * 2019-11-26 2021-05-27 Henkel Ag & Co. Kgaa Verfahren zur Entfärbung von keratinischem Material, das durch Anwendung eines Aminosilikons und eines Pigments gefärbt wurde
EP4251142A4 (fr) * 2020-11-30 2025-04-09 Sophrosyne Pharmaceuticals Limited Composes et méthodes de traitement d'un trouble lié à la consommation d'alcool

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1081859B (de) * 1957-12-06 1960-05-19 Basf Ag Salze der Hydroxymethan-oder Hydroxyaethansulfinsaeure enthaltende Zubereitungen zur Herstellung haltbarer, saurer Abziehbaeder
BE648012A (fr) * 1964-11-15 1964-11-16
DE1617829B2 (de) 1966-06-03 1974-06-27 Hans Schwarzkopf Gmbh, 2000 Hamburg Verstärkungsmittel für das Blondieren von lebenden Haaren mit Wasserstoffsuperoxyd
US3892845A (en) 1972-09-29 1975-07-01 Avon Prod Inc Hair shade adjuster
DE3723354A1 (de) 1987-07-15 1989-01-26 Henkel Kgaa Sulfatierte hydroxy-mischether, verfahren zu ihrer herstellung und ihre verwendung
DE3725030A1 (de) 1987-07-29 1989-02-09 Henkel Kgaa Oberflaechenaktive hydroxysulfonate
DE3926344A1 (de) 1989-08-09 1991-02-28 Henkel Kgaa Verfahren zur herstellung von hellfarbigen oelsaeuresulfonaten
DE19717281A1 (de) 1997-04-24 1998-10-29 Henkel Kgaa Verwendung von Benzoylidenketonen zum Färben von keratinhaltigen Fasern
DE19743759A1 (de) * 1997-10-02 1999-04-08 Brueggemann L Kg Sulfinsäurederivate und deren Herstellung und Verwendung
FR2785183B1 (fr) 1998-11-04 2002-04-05 Oreal COMPOSITION TINCTORIALE CONTENANT UN COLORANT DIRECT CATIONIQUE ET UNE PYRAZOLO-[1,5-a]- PYRIMIDINE A TITRE DE BASE D'OXYDATION, ET PROCEDES DE TEINTURE
US6159485A (en) * 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
DE19940068A1 (de) 1999-08-24 2001-03-01 Basf Ag Verfahren zum Aufhellen von gefärbtem Textilmaterial
FR2814948B1 (fr) * 2000-10-11 2003-01-10 Oreal Composition cosmetique contenant des derives d'acide sulfinique
FR2829764B1 (fr) * 2001-09-17 2003-12-19 Oreal Composition cosmetique contenant des derives d'acide sulfinique
FR2830009B1 (fr) 2001-09-26 2004-10-01 Oreal Composition cosmetique contenant des derives d'acide sulfinique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007107309A2 *

Also Published As

Publication number Publication date
EP2283899A1 (fr) 2011-02-16
EP2283899B1 (fr) 2017-07-19
WO2007107309A3 (fr) 2008-05-15
WO2007107309A2 (fr) 2007-09-27

Similar Documents

Publication Publication Date Title
EP2056780B1 (fr) Décoloration par réduction
DE202004003165U1 (de) Oxidationsfärbemittel
EP2152226A2 (fr) Colorants d'oxydation destinés à colorer des fibres kératiniques au moyen d'oxygène atmosphérique comme unique agent d'oxydation
EP1996145A2 (fr) Décoloration réductive
EP2001557A2 (fr) Décoloration réductive
DE20017642U1 (de) Oxidationsfärbemittel mit 2-Chlor-4-aminophenol
EP2069022A2 (fr) Agent de coloration de fibres kératiniques
EP2001558A2 (fr) Décoloration réductive
DE10103657A1 (de) Neue Kupplerkomponente für Oxidationsmittel
DE102006022274A1 (de) Reduktiver Farbabzug
DE102006023116A1 (de) Organische Sulfinsäurederivate
EP2277597B1 (fr) Décoloration réductive
EP2277598B1 (fr) Décoloration réductive
EP1309540B1 (fr) Colorants d'oxydation
DE10103160A1 (de) Neue Kupplerkomponente für Oxidationsfärbemittel
DE102006022215A1 (de) Reduktiver Farbabzug
DE102006022225A1 (de) Reduktiver Farbabzug
DE102006022228A1 (de) Reduktiver Farbabzug
EP1272150B1 (fr) Colorants contenant des composes de ruthenium
DE102006022214A1 (de) Reduktiver Farbabzug
DE102006053343A1 (de) Verfahren für den reduktiven Farbabzug
EP1351657A2 (fr) Colorants hybrides revelateur/revelateur et produits primaires desdits colorants
EP1888018A1 (fr) Agents pour colorer des fibres a base de keratine
DE10051032A1 (de) Oxidationsfärbemittel mit 2-Chlor-p-aminophenol
WO2003053385A1 (fr) Nouveaux colorants d'oxydation contenant du 2,4-dichloro-3-aminophenol

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080530

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20080515

17Q First examination report despatched

Effective date: 20100527

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101207